ALK and non-small cell lung carcinoma: In addition, ALK fusion proteins have been reported in nonelastic ALCL, inflammatory myofibrosarcoma (IMT), diffuse large B-cell lymphoma (DLBCL), and non-small cell lung cancer (NSCLC) [64].